Molina Healthcare, Inc.: Form 10-K for the period ended Dec 31, 2020
Filed with the SEC on Feb 16, 2021 and accepted by EDGAR at Feb 16, 2021, 09:05 ET.
Sections
No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2020-01-01 to 2020-12-31 | $19.42bn | us-gaap:Revenues |
| Gross profit | 12 months2020-01-01 to 2020-12-31 | $2.48bn | us-gaap:GrossProfit |
| Operating income | 12 months2020-01-01 to 2020-12-31 | $1.08bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2020-01-01 to 2020-12-31 | $102.0m | us-gaap:InterestExpense |
| Income tax | 12 months2020-01-01 to 2020-12-31 | $288.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2020-01-01 to 2020-12-31 | $673.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2020-01-01 to 2020-12-31 | $11.23 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2020-01-01 to 2020-12-31 | $11.40 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2020-01-01 to 2020-12-31 | 59,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2020-01-01 to 2020-12-31 | $1.89bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2020-01-01 to 2020-12-31 | $74.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2020-01-01 to 2020-12-31 | $606.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2020-12-31 | $4.15bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-12-31 | $7.88bn | us-gaap:AssetsCurrent |
| Total assets | At period end2020-12-31 | $9.53bn | us-gaap:Assets |
| Current liabilities | At period end2020-12-31 | $4.96bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-12-31 | $7.44bn | us-gaap:Liabilities |
| Long-term debt | At period end2020-12-31 | $2.13bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2020-12-31 | $0 | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2020-12-31 | $2.10bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001179929-21-000024. Last ingested by Listed: Nov 15, 2026, 00:39 ET. Listed shows no prices and gives no investment advice.